We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$617M
AUM Growth
+$35M
Cap. Flow
+$8.76M
Cap. Flow %
1.42%
Top 10 Hldgs %
41.08%
Holding
84
New
4
Increased
23
Reduced
31
Closed
2

Top Buys

Rank Stock Value
1
PODD icon
Insulet
PODD
+$9.66M
2
DXCM icon
DexCom
DXCM
+$8.61M
3
MTD icon
Mettler-Toledo International
MTD
+$524K
4
BIIB icon
Biogen
BIIB
+$395K
5
NEOG icon
Neogen
NEOG
+$308K

Sector Composition

Rank Sector Weight
1 Healthcare 32.75%
2 Technology 15.49%
3 Industrials 11.13%
4 Consumer Staples 10.6%
5 Energy 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.5B
$38.2M 6.19%
121,170
+1,313
+1% +$395K
TIF
2
DELISTED
Tiffany & Co.
TIF
$36.3M 5.88%
361,724
-4,055
-1% -$376K
SSYS icon
3
Stratasys
SSYS
$701M
$27.6M 4.47%
242,820
+1,191
+0.5% +$117K
BF.B icon
4
Brown-Forman Class B
BF.B
$12.1B
$24.9M 4.04%
827,113
-6,600
-0.8% -$193K
JNJ icon
5
Johnson & Johnson
JNJ
$599B
$24.4M 3.96%
233,682
-6,191
-3% -$626K
SLB icon
6
SLB Ltd
SLB
$69.4B
$23.1M 3.74%
195,837
-1,584
-0.8% -$163K
CGNX icon
7
Cognex
CGNX
$10.5B
$20.3M 3.29%
1,055,980
+2,210
+0.2% +$39K
DHR icon
8
Danaher
DHR
$142B
$20.2M 3.27%
381,252
+391
+0.1% +$20.1K
GWW icon
9
W.W. Grainger
GWW
$64.7B
$19.4M 3.14%
76,275
+265
+0.3% +$67.7K
NVO
10
Novo Nordisk
NVO
$219B
$19M 3.09%
824,440
+6,060
+0.7% +$134K
ADI icon
11
Analog Devices
ADI
$181B
$18.1M 2.93%
334,464
-4,170
-1% -$221K
SYT
12
DELISTED
Syngenta Ag
SYT
$16.8M 2.73%
224,983
-19
-0% -$1.46K
HON icon
13
Honeywell
HON
$71.7B
$16.3M 2.65%
195,494
-3,478
-2% -$291K
KOF icon
14
Coca-Cola Femsa
KOF
$21.8B
$15M 2.43%
132,126
-580
-0.4% -$65.4K
NEOG icon
15
Neogen
NEOG
$2.18B
$14.7M 2.38%
969,272
+20,720
+2% +$308K
TRMB icon
16
Trimble
TRMB
$12.4B
$14.1M 2.28%
380,251
+3,300
+0.9% +$123K
RTN
17
DELISTED
Raytheon Company
RTN
$13.8M 2.24%
149,952
-2,257
-1% -$219K
HSIC icon
18
Henry Schein
HSIC
$9.82B
$13.3M 2.15%
285,613
-2,682
-0.9% -$123K
IDXX icon
19
Idexx Laboratories
IDXX
$44.5B
$12.5M 2.03%
187,430
+100
+0.1% +$6.36K
CTXS
20
DELISTED
Citrix Systems Inc
CTXS
$12.4M 2.01%
249,215
-24,336
-9% -$1.17M
AMGN icon
21
Amgen
AMGN
$197B
$11.8M 1.92%
99,942
-456
-0.5% -$52.8K
DXCM icon
22
DexCom
DXCM
$29.2B
$11M 1.79%
1,112,300
+971,900
+692% +$8.61M
WSM icon
23
Williams-Sonoma
WSM
$26.3B
$10.7M 1.74%
299,060
-3,700
-1% -$122K
GE icon
24
GE Aerospace
GE
$354B
$10.6M 1.72%
84,135
-8,357
-9% -$1.06M
OXY icon
25
Occidental Petroleum
OXY
$54.9B
$10.4M 1.68%
105,359
-1,586
-1% -$149K

Similar funds

Tirschwell & Loewy's Q2 2014 Portfolio in Review

As of Q2 2014, Tirschwell & Loewy held 84 positions worth $617M, up 6% from $582M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Tirschwell & Loewy's Q2 2014 filing shows 4 new, 23 increased, 31 reduced and 2 closed positions. Its largest new stake was Insulet: 251,475 shares worth $9.98M. The largest sale was iShares MSCI Hong Kong ETF, an estimated $3.82M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q2 2014 buy was Insulet: 251,475 shares worth $9.98M.
  • Tirschwell & Loewy added most to DexCom in Q2 2014, an estimated $8.61M increase.
  • Tirschwell & Loewy's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $1.17M.
  • Tirschwell & Loewy fully exited iShares MSCI Hong Kong ETF in Q2 2014, selling an estimated $3.82M.
  • Tirschwell & Loewy's ten largest holdings make up 41% of its $617M portfolio in Q2 2014.
  • Tirschwell & Loewy opened 4 new positions and closed 2 in Q2 2014.
  • Tirschwell & Loewy's portfolio value rose 6% quarter-over-quarter to $617M.

Based on Tirschwell & Loewy's 13F filing for Q2 2014, filed 25 Jul 2014.